CytomX Therapeutics, Inc. (CTMX)
4.11
-0.14
(-3.29%)
USD |
NASDAQ |
Dec 17, 16:00
4.20
+0.09
(+2.19%)
After-Hours: 04:48
CytomX Therapeutics EPS Diluted (Quarterly): -0.0862 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.23M |
| Revenue (Quarterly) | 5.963M |
| Total Expenses (Quarterly) | 20.19M |
| Enterprise Value | 558.35M |
| Gross Profit Margin (Quarterly) | 97.75% |
| Profit Margin (Quarterly) | -238.6% |
| Earnings Yield | 10.18% |
| Operating Earnings Yield | 4.88% |
| Normalized Earnings Yield | 10.16 |